Literature DB >> 17220560

Nuclear receptor-mediated transcriptional regulation in Phase I, II, and III xenobiotic metabolizing systems.

Kotoko Nakata1, Yoshitomo Tanaka, Tatsuya Nakano, Tatsuhiko Adachi, Hiroshi Tanaka, Tsuguchika Kaminuma, Toshihisa Ishikawa.   

Abstract

Studies of the genetic regulation involved in drug metabolizing enzymes and drug transporters are of great interest to understand the molecular mechanisms of drug response and toxic events. Recent reports have revealed that hydrophobic ligands and several nuclear receptors are involved in the induction or down-regulation of various enzymes and transporters involved in Phase I, II, and III xenobiotic metabolizing systems. Nuclear receptors (NRs) form a family of ligand-activated transcription factors (TFs). These proteins modulate the regulation of target genes by contacting their promoter or enhancer sequences at specific recognition sites. These target genes include metabolizing enzymes such as cytochrome P450s (CYPs), transporters, and NRs. Thus it was now recognized that these NRs play essential role in sensing processing xenobiotic substances including drugs, environmental chemical pollutants and nutritional ingredients. From literature, we picked up target genes of each NR in xenobiotic response systems. Possible cross-talk, by which xenobiotics may exert undesirable effects, was listed. For example, the role of NRs was comprehensively drawn up in cholesterol and bile acid homeostasis in human hepatocyte. Summarizing current states of related research, especially for in silico response element search, we tried to elucidate nuclear receptor mediated xenobiotic processing loops and direct future research.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17220560     DOI: 10.2133/dmpk.21.437

Source DB:  PubMed          Journal:  Drug Metab Pharmacokinet        ISSN: 1347-4367            Impact factor:   3.614


  33 in total

1.  MAPK-directed activation of the whitefly transcription factor CREB leads to P450-mediated imidacloprid resistance.

Authors:  Xin Yang; Shun Deng; Xuegao Wei; Jing Yang; Qiannan Zhao; Cheng Yin; Tianhua Du; Zhaojiang Guo; Jixing Xia; Zezhong Yang; Wen Xie; Shaoli Wang; Qingjun Wu; Fengshan Yang; Xuguo Zhou; Ralf Nauen; Chris Bass; Youjun Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2020-04-23       Impact factor: 11.205

2.  Phase I to II cross-induction of xenobiotic metabolizing enzymes: a feedforward control mechanism for potential hormetic responses.

Authors:  Qiang Zhang; Jingbo Pi; Courtney G Woods; Melvin E Andersen
Journal:  Toxicol Appl Pharmacol       Date:  2009-04-14       Impact factor: 4.219

Review 3.  Emerging roles of Nrf2 and phase II antioxidant enzymes in neuroprotection.

Authors:  Meijuan Zhang; Chengrui An; Yanqin Gao; Rehana K Leak; Jun Chen; Feng Zhang
Journal:  Prog Neurobiol       Date:  2012-09-29       Impact factor: 11.685

Review 4.  Hydrodynamic gene delivery and its applications in pharmaceutical research.

Authors:  Barbara Bonamassa; Li Hai; Dexi Liu
Journal:  Pharm Res       Date:  2010-12-30       Impact factor: 4.200

5.  A novel in vitro pancreatic carcinogenesis model.

Authors:  Hyo Jin Kang; Young Bin Hong; Hee Jeong Kim; Yong Weon Yi; Raghu G Nath; Young Soo Chang; Ho-Chan Cho; Insoo Bae
Journal:  Toxicol Lett       Date:  2011-01-20       Impact factor: 4.372

Review 6.  Current industrial practices in assessing CYP450 enzyme induction: preclinical and clinical.

Authors:  Michael Sinz; Gillian Wallace; Jasminder Sahi
Journal:  AAPS J       Date:  2008-08-07       Impact factor: 4.009

Review 7.  Nuclear receptors as therapeutic targets in cholestatic liver diseases.

Authors:  Gernot Zollner; Michael Trauner
Journal:  Br J Pharmacol       Date:  2009-01       Impact factor: 8.739

8.  Broccoli sprout extract induces detoxification-related gene expression and attenuates acute liver injury.

Authors:  Kazutaka Yoshida; Yusuke Ushida; Tomoko Ishijima; Hiroyuki Suganuma; Takahiro Inakuma; Nobuhiro Yajima; Keiko Abe; Yuji Nakai
Journal:  World J Gastroenterol       Date:  2015-09-21       Impact factor: 5.742

9.  NRF2 modulates aryl hydrocarbon receptor signaling: influence on adipogenesis.

Authors:  Soona Shin; Nobunao Wakabayashi; Vikas Misra; Shyam Biswal; Gum Hwa Lee; Elin S Agoston; Masayuki Yamamoto; Thomas W Kensler
Journal:  Mol Cell Biol       Date:  2007-08-20       Impact factor: 4.272

10.  Three-dimensional Huh7 cell culture system for the study of Hepatitis C virus infection.

Authors:  Bruno Sainz; Veronica TenCate; Susan L Uprichard
Journal:  Virol J       Date:  2009-07-15       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.